Wnt/β‑catenin signaling modulates piperine‑mediated antitumor effects on human osteosarcoma cells

Qi,Yu‑Bin; Yang,Wen; Si,Meng; Nie,Lin

doi:10.3892/mmr.2020.11000

Wnt/β‑catenin signaling modulates piperine‑mediated antitumor effects on human osteosarcoma cells

Authors:
- Yu‑Bin Qi
- Wen Yang
- Meng Si
- Lin Nie
View Affiliations

Affiliations: Department of Orthopedics, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Spinal Surgery, Heze Municipal Hospital, Heze, Shandong 274031, P.R. China
Published online on: February 26, 2020 https://doi.org/10.3892/mmr.2020.11000
Pages: 2202-2208
Copyright: © Qi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The plant extract piperine is used as a traditional Chinese medicine due to its anti‑inflammatory effects and efficacy against numerous types of cancer. The aim of the present study was to investigate the antitumor mechanism of piperine in human osteosarcoma U2OS and 143B cell lines. The effects of piperine on cell apoptosis and invasion of human osteosarcoma cells were assessed using flow cytometry and Transwell assays. Moreover, western blotting was used to measure the effects of piperine on the protein expression levels of the metastasis markers matrix metalloproteinase‑2 (MMP‑2) and vascular endothelial growth factor (VEGF). In addition, the involvement of the Wnt/β‑catenin signaling pathway in modulating the effects of piperine was examined via western blot analysis. The results of MTT and Transwell invasion assays indicated that piperine treatment dose‑dependently reduced U2OS and 143B cell viability and invasion. Furthermore, a significant reduction was identified in MMP‑2, VEGF, glycogen synthase kinase‑3β and β‑catenin protein expression levels, as well as the expression levels of their target proteins cyclooxygenase‑2, cyclin D1 and c‑myc, in U2OS cells after piperine treatment. In addition, similar results were observed in 143B cells. Therefore, the present study demonstrated the efficacy of piperine in osteosarcoma, and identified that the Wnt/β‑catenin signaling pathway may modulate the antitumor effects of piperine on human U2OS and 143B cells.

View Figures

View References

1	Petriceks AH and Salmi D: Educational case: Primary osteosarcoma. Acad Pathol. 6:23742895188203372019. View Article : Google Scholar : PubMed/NCBI
2	Pu F, Chen F, Chen S, Wang B, Liu J and Shao Z: Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: A meta-analysis. Onco Targets Ther. 8:1835–1842. 2015.PubMed/NCBI
3	Van de Luijtgaarden AC, Kapusta L, Bellersen L, Bokkerink JP, Kaal SE, Versleijen-Jonkers YM, Schreuder HW and van der Graaf WT: High prevalence of late adverse events in malignant bone tumour survivors diagnosed at adult age. Neth J Med. 72:516–522. 2014.PubMed/NCBI
4	Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S and Strauss SJ: Incidence and survival of malignant bone sarcomas in England 1979–2007. Int J Cancer. 131:E508–E517. 2012. View Article : Google Scholar : PubMed/NCBI
5	Castillo-Tandazo W, Mutsaers AJ and Walkley CR: Osteosarcoma in the post genome Era: Preclinical models and approaches to identify tractable therapeutic targets. Curr Osteoporos Rep. 17:343–352. 2019. View Article : Google Scholar : PubMed/NCBI
6	Moore DD and Luu HH: Osteosarcoma. Cancer Treat Res. 162:65–92. 2014. View Article : Google Scholar : PubMed/NCBI
7	Zheng J, Zhou Y, Li Y, Xu DP, Li S and Li HB: Spices for prevention and treatment of cancers. Nutrients. 8:E4952016. View Article : Google Scholar : PubMed/NCBI
8	Parthasarathy N, Selwyn MA and Udayakumar M: Tropical dry evergreen forests of 627 peninsular India: Ecology and conservation significance. Trop Conservation Sci. 1:89–110. 2008. View Article : Google Scholar
9	Mehmood MH and Gilani AH: Pharmacological basis for the medicinal use of black pepper and piperine in gastrointestinal disorders. J Med Food. 13:1086–1096. 2010. View Article : Google Scholar : PubMed/NCBI
10	Liu J, Chen M, Wang X, Wang Y, Duan C, Gao G, Lu L, Wu X, Wang X and Yang H: Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson's disease model. Oncotarget. 7:60823–60843. 2016.PubMed/NCBI
11	Aumeeruddy MZ and Mahomoodally MF: Combating breast cancer using combination therapy with 3 phytochemicals: Piperine, sulforaphane, and thymoquinone. Cancer. 125:1600–1611. 2019. View Article : Google Scholar : PubMed/NCBI
12	Lin Y, Xu J, Liao H, Li L and Pan L: Piperine induces apoptosis of lung cancer a549 cells via p53-dependent mitochondrial signaling pathway. Tumour Biol. 35:3305–3310. 2014. View Article : Google Scholar : PubMed/NCBI
13	Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK and Fromm MF: Piperine, a major constituent of black pepper, inhibits human p-glycoprotein and cyp3a4. J Pharmacol Exp Ther. 302:645–650. 2002. View Article : Google Scholar : PubMed/NCBI
14	Sunila ES and Kuttan G: Immunomodulatory and antitumor activity of piper longum linn and piperine. J Ethnopharmacol. 90:339–346. 2004. View Article : Google Scholar : PubMed/NCBI
15	Greenshields AL, Doucette CD, Sutton KM, Madera L, Annan H, Yaffe PB, Knickle AF, Dong Z and Hoskin DW: Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 357:129–140. 2015. View Article : Google Scholar : PubMed/NCBI
16	Gunasekaran V, Elangovan K and Niranjali Devaraj S: Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. Food Chem Toxicol. 105:106–118. 2017. View Article : Google Scholar : PubMed/NCBI
17	Hwang YP, Yun HJ, Kim HG, Han EH, Choi JH, Chung YC and Jeong HG: Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression. Toxicol Lett. 203:9–19. 2011. View Article : Google Scholar : PubMed/NCBI
18	Pathak N and Khandelwal S: Cytoprotective and immunomodulating properties of piperine on murine splenocytes: An in vitro study. Eur J Pharmacol. 576:160–170. 2007. View Article : Google Scholar : PubMed/NCBI
19	Taqvi SI, Shah AJ and Gilani AH: Blood pressure lowering and vasomodulator effects of piperine. J Cardiovasc Pharmacol. 52:452–458. 2008. View Article : Google Scholar : PubMed/NCBI
20	Wattanathorn J, Chonpathompikunlert P, Muchimapura S, Priprem A and Tankamnerdthai O: Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol. 46:3106–3110. 2008. View Article : Google Scholar : PubMed/NCBI
21	Zhang J, Zhu X, Li H, Li B, Sun L, Xie T, Zhu T, Zhou H and Ye Z: Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Int Immunopharmacol. 24:50–58. 2015. View Article : Google Scholar : PubMed/NCBI
22	Pan H, Xu LH, Huang MY, Zha QB, Zhao GX, Hou XF, Shi ZJ, Lin QR, Ouyang DY and He XH: Piperine metabolically regulates peritoneal resident macrophages to potentiate their functions against bacterial infection. Oncotarget. 6:32468–32483. 2015. View Article : Google Scholar : PubMed/NCBI
23	Oudin MJ and Weaver VM: Physical and chemical gradients in the tumor microenvironment regulate tumor cell invasion, migration, and metastasis. Cold Spring Harb Symp Quant Biol. 81:189–205. 2016. View Article : Google Scholar : PubMed/NCBI
24	Li H, Zhang K, Liu LH, Ouyang Y, Bu J, Guo HB and Xiao T: A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma. Tumour Biol. 35:5487–5491. 2014. View Article : Google Scholar : PubMed/NCBI
25	Fromigue O, Hamidouche Z and Marie PJ: Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem. 283:30549–30556. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ling L, Nurcombe V and Cool SM: Wnt signaling controls the fate of mesenchymal stem cells. Gene. 433:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
27	Peng N, Gao S, Guo X, Wang G, Cheng C, Li M and Liu K: Silencing of VEGF inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT signaling pathway. Am J Transl Res. 8:1005–1015. 2016.PubMed/NCBI
28	Manzano-Moreno FJ, Costela-Ruiz VJ, Melguizo-Rodríguez L, Illescas-Montes R, García-Martínez O, Ruiz C and Ramos-Torrecillas J: Inhibition of VEGF gene expression in osteoblast cells by different NSAIDs. Arch Oral Biol. 92:75–78. 2008. View Article : Google Scholar
29	Olivares-Navarrete R, Hyzy S, Wieland M, Boyan BD and Schwartz Z: The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces. Biomaterials. 31:2015–2024. 2010. View Article : Google Scholar : PubMed/NCBI
30	Tian J, He H and Lei G: Wnt/β-catenin pathway in bone cancers. Tumour Biol. 35:9439–9445. 2014. View Article : Google Scholar : PubMed/NCBI
31	Brafman D and Willert K: Wnt/β-catenin signaling during early vertebrate neural development. Dev Neurobiol. 77:1239–1259. 2017. View Article : Google Scholar : PubMed/NCBI
32	Di Fiore R, Guercio A, Puleio R, Di Marco P, Drago-Ferrante R, D'Anneo A, De Blasio A, Carlisi D, Di Bella S, Pentimalli F, et al: Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts. J Cell Biochem. 113:3380–3392. 2012. View Article : Google Scholar : PubMed/NCBI
33	Katoh M and Katoh M: Molecular genetics and targeted therapy of WNT-related human diseases (Review). Int J Mol Med. 40:587–606. 2017.PubMed/NCBI
34	Krishnamurthy N and Kurzrock R: Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar : PubMed/NCBI
35	Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, Hsu FD, West RB and Nielsen TO: Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 18:68–74. 2005. View Article : Google Scholar : PubMed/NCBI
36	Ghosh N, Hossain U, Mandal A and Sil PC: The wnt signaling pathway: A potential therapeutic target against cancer. Ann N Y Acad Sci. 1443:54–74. 2019. View Article : Google Scholar : PubMed/NCBI
37	Zhang X, Qu P, Zhao H, Zhao T and Cao N: Cox 2 promotes epithelial-mesenchymal transition and migration in osteosarcoma MG 63 cells via PI3K/AKT/NF kB signaling. Mol Med Rep. 20:3811–3819. 2019.PubMed/NCBI
38	Liu G, Yuan D, Sun P, Liu W, Wu PF, Liu H and Yu GY: Linc00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling. J Cell Physiol. 233:8639–8647. 2018. View Article : Google Scholar : PubMed/NCBI
39	Zhang J, Yu XH, Yan YG, Wang C and Wang WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta. 444:182–192. 2015. View Article : Google Scholar : PubMed/NCBI
40	Graziano AC, Cardile V, Avola R, Vicario N, Parenti C, Salvatorelli L, Magro G and Parenti R: Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. Oncotarget. 8:13917–13931. 2017. View Article : Google Scholar : PubMed/NCBI
41	Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, et al: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci USA. 111:E5564–E5573. 2014. View Article : Google Scholar : PubMed/NCBI
42	Yoo ES, Choo GS, Kim SH, Woo JS, Kim HJ, Park YS, Kim BS, Kim SK, Park BK, Cho SD, et al: Antitumor and apoptosis-inducing effects of piperine on human melanoma cells. Anticancer Res. 39:1883–1892. 2019. View Article : Google Scholar : PubMed/NCBI
43	Lai LH, Fu QH, Liu Y, Jiang K, Guo QM, Chen QY, Yan B, Wang QQ and Shen JG: Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin. 33:523–530. 2012. View Article : Google Scholar : PubMed/NCBI